Generate a tailored SOP for Dr. Angelika Harbauer. Improve your application with a focused, well-structured draft.
Prof. Angelika Harbauer studies neuron metabolism, focusing on mitochondrial biogenesis. Her research addresses how small disturbances in energy conversion can lead to the production of toxic reactive oxygen species, making rigorous mitochondrial quality control essential for cellular survival. Inadequately addressed, damaged mitochondria can cause neurodegenerative diseases, most notably Parkinson's disease. Her laboratory investigates the mechanisms and signals that help adapt mitochondrial output to surrounding environments, ensuring functionality, particularly in neurons. Prof. Harbauer studied Molecular Medicine at the University of Freiburg and completed her PhD at the Institute for Biochemistry and Molecular Biology under Prof. Meisinger. Between 2015 and 2019, she conducted postdoctoral research in the lab of Prof. Tom Schwarz at Boston Children’s Hospital/Harvard Medical School. In September 2019, she became a Max-Planck Research Group Leader at the MPI of Neurobiology in Martinsried and was appointed to the Professorship in Neuron Metabolism at TUM the same month.
Max-Planck Institute for Neurobiology • Martinsried
Leading a research group focused on neuron metabolism and mitochondrial function.
Boston Children's Hospital / Harvard Medical School • Boston
Conducted research in the lab of Prof. Tom Schwarz.